{"id":85971,"date":"2019-10-07T12:56:24","date_gmt":"2019-10-07T08:56:24","guid":{"rendered":""},"modified":"-0001-11-30T00:00:00","modified_gmt":"-0001-11-29T20:00:00","slug":"","status":"publish","type":"post","link":"https:\/\/ucnoqta.az\/?p=85971","title":{"rendered":"\u00d6t\u0259n il Az\u0259rbaycanda talassemiyadan 13, leykemiyadan 183 n\u0259f\u0259r \u00f6l\u00fcb"},"content":{"rendered":"<p><strong>&Ouml;t\u0259n il talassemiya diaqnozu il\u0259 ilk d\u0259f\u0259 qeyd\u0259 &nbsp;al\u0131nm\u0131\u015f &nbsp;x\u0259st\u0259l\u0259rin say\u0131 418 n\u0259f\u0259r olub. Onlardan 243 n\u0259f\u0259ri ki\u015fi, 175 n\u0259f\u0259ri is\u0259 qad\u0131nd\u0131r.<\/strong><\/p>\n<p>D&ouml;vl\u0259t Statistika Komit\u0259sind\u0259n&nbsp;APA-n\u0131n sor\u011fusuna cavab olaraq bildirilib ki, x\u0259st\u0259l\u0259rd\u0259n&nbsp;144-&uuml; ki\u015fi, 88-i qad\u0131n olmaqla 232 n\u0259f\u0259ri 0-17 ya\u015f qrupuna, 38-i ki\u015fi, 30-u qad\u0131n olmaqla 68 n\u0259f\u0259ri &nbsp;18-29 ya\u015f qrupuna, 61-i ki\u015fi, 57-si qad\u0131n olmaqla 118 n\u0259f\u0259ri 30 v\u0259 yuxar\u0131 ya\u015f qrupuna aiddir.<\/p>\n<p>M&uuml;alic\u0259-profilaktika m&uuml;\u0259ssis\u0259l\u0259rind\u0259 talassemiya diaqnozu il\u0259 qeydiyyatda olan x\u0259st\u0259l\u0259rin say\u0131 ilin sonuna olan m\u0259lumata \u0259sas\u0259n, 3700 n\u0259f\u0259r olub. Onlardan 2157-si ki\u015fi, 1543-&uuml; qad\u0131nd\u0131r. H\u0259min \u015f\u0259xsl\u0259rd\u0259n 2046 n\u0259f\u0259ri 0-17 ya\u015f qrupuna, 810 n\u0259f\u0259ri 18-29 ya\u015f qrupuna, 844 n\u0259f\u0259ri 30 v\u0259 yuxar\u0131 ya\u015f qrupuna aiddir.<\/p>\n<p>Komit\u0259d\u0259n bildirilib ki, &ouml;t\u0259n il hemofiliya diaqnozu il\u0259 ilk d\u0259f\u0259 qeyd\u0259 &nbsp;al\u0131nm\u0131\u015f &nbsp;x\u0259st\u0259l\u0259rin say\u0131 76-s\u0131 ki\u015fi, 28-i qad\u0131n olmaqla 104 n\u0259f\u0259r olub. X\u0259st\u0259l\u0259rd\u0259n 42 n\u0259f\u0259ri 0-17 ya\u015f aral\u0131\u011f\u0131nda, 25 n\u0259f\u0259ri 18-29 ya\u015f aral\u0131\u011f\u0131nda, 37 n\u0259f\u0259ri 30 v\u0259 yuxar\u0131 ya\u015f aral\u0131\u011f\u0131nda olanlard\u0131r.<br \/>\nM\u0259lumatda qeyd olunub ki, 2018-ci ild\u0259 limfoid leykemiya diaqnozu il\u0259 qeyd\u0259 &nbsp;al\u0131nan &nbsp;x\u0259st\u0259l\u0259rin say\u0131 162 n\u0259f\u0259r olub. Onlardan 85 n\u0259f\u0259rini ki\u015fi, 77 n\u0259f\u0259rini qad\u0131nlar t\u0259\u015fkil edir. X\u0259st\u0259l\u0259rd\u0259n 22-si 0-17,&nbsp;17-si 18-29,&nbsp;123-&uuml;&nbsp;30 v\u0259 yuxar\u0131 ya\u015f qrupuna aiddir.<\/p>\n<p>&Ouml;t\u0259n il mieloid leykemiya diaqnozu il\u0259 ilk d\u0259f\u0259 qeyd\u0259 &nbsp;al\u0131nm\u0131\u015f &nbsp;x\u0259st\u0259l\u0259rin say\u0131 is\u0259 63 n\u0259f\u0259r olub. Onlardan 31-i ki\u015fi, 32-si qad\u0131nd\u0131r. X\u0259st\u0259l\u0259rd\u0259n 4 n\u0259f\u0259ri &nbsp;0-17,&nbsp;4 n\u0259f\u0259ri 18-29,&nbsp;55 n\u0259f\u0259ri is\u0259 30 v\u0259 yuxar\u0131 ya\u015f aral\u0131\u011f\u0131na malik \u015f\u0259xsl\u0259rdir.<br \/>\n&Ouml;t\u0259n il talassemiya x\u0259st\u0259liyind\u0259n 5-i ki\u015fi, 8-i qad\u0131n olmaqla 13 n\u0259f\u0259r &ouml;l&uuml;b. Onlardan 8 n\u0259f\u0259ri 0-17 ya\u015f qrupuna, 3 n\u0259f\u0259ri 18-29 ya\u015f qrupuna, 3 n\u0259f\u0259ri 30 v\u0259 yuxar\u0131 ya\u015f qrupuna aid \u015f\u0259xsl\u0259rdir.<\/p>\n<p>2018-ci ild\u0259 hemofiliyadan 1 ki\u015fi d&uuml;nyas\u0131n\u0131 d\u0259yi\u015fib. &nbsp;Limfoid leykemiya x\u0259st\u0259liyind\u0259n &ouml;l\u0259nl\u0259rin say\u0131 66-s\u0131 ki\u015fi, 45-i qad\u0131n olmaqla 111 n\u0259f\u0259r olub. Onlardan 17 n\u0259f\u0259ri 0-17,&nbsp;12 n\u0259f\u0259ri 18-29,&nbsp;82 n\u0259f\u0259ri 30 v\u0259 yuxar\u0131 ya\u015f qrupuna aiddir.<br \/>\nMieloid leykemiya x\u0259st\u0259liyind\u0259n is\u0259 37-si ki\u015fi, 35-i qad\u0131n olmaqla 72 n\u0259f\u0259r &ouml;l&uuml;b. Onlardan 2-si 0-17,&nbsp;5-i 18-29, 65-i 30 v\u0259 yuxar\u0131 ya\u015f aral\u0131\u011f\u0131nda olan \u015f\u0259xsl\u0259rdir.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&Ouml;t\u0259n il talassemiya diaqnozu il\u0259 ilk d\u0259f\u0259 qeyd\u0259 &nbsp;al\u0131nm\u0131\u015f &nbsp;x\u0259st\u0259l\u0259rin say\u0131 418 n\u0259f\u0259r olub. Onlardan 243 n\u0259f\u0259ri ki\u015fi, 175 n\u0259f\u0259ri is\u0259 qad\u0131nd\u0131r. D&ouml;vl\u0259t Statistika Komit\u0259sind\u0259n&nbsp;APA-n\u0131n sor\u011fusuna cavab olaraq bildirilib ki,&hellip;<\/p>\n","protected":false},"author":1,"featured_media":251278,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[],"tags":[],"class_list":["post-85971","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/posts\/85971","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=85971"}],"version-history":[{"count":0,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/posts\/85971\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/media\/251278"}],"wp:attachment":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=85971"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=85971"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=85971"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}